Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does PACLITAXEL Cause Electrocardiogram qt prolonged? 108 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 108 reports of Electrocardiogram qt prolonged have been filed in association with PACLITAXEL (PACLITAXEL PACLITAXEL). This represents 0.1% of all adverse event reports for PACLITAXEL.

108
Reports of Electrocardiogram qt prolonged with PACLITAXEL
0.1%
of all PACLITAXEL reports
3
Deaths
43
Hospitalizations

How Dangerous Is Electrocardiogram qt prolonged From PACLITAXEL?

Of the 108 reports, 3 (2.8%) resulted in death, 43 (39.8%) required hospitalization, and 6 (5.6%) were considered life-threatening.

Is Electrocardiogram qt prolonged Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for PACLITAXEL. However, 108 reports have been filed with the FAERS database.

What Other Side Effects Does PACLITAXEL Cause?

Neutropenia (4,553) Nausea (4,521) Dyspnoea (4,519) Diarrhoea (4,289) Off label use (4,075) Anaemia (3,949) Neuropathy peripheral (3,508) Malignant neoplasm progression (3,484) Fatigue (3,418) Death (3,143)

What Other Drugs Cause Electrocardiogram qt prolonged?

QUETIAPINE (1,869) OLANZAPINE (1,325) RIBOCICLIB (1,020) AMIODARONE (1,000) HYDROXYCHLOROQUINE (992) CLOZAPINE (958) CITALOPRAM HYDROBROMIDE (917) ESCITALOPRAM OXALATE (899) ONDANSETRON (881) BUPROPION (853)

Which PACLITAXEL Alternatives Have Lower Electrocardiogram qt prolonged Risk?

PACLITAXEL vs PACRITINIB PACLITAXEL vs PALBOCICLIB PACLITAXEL vs PALIPERIDONE PACLITAXEL vs PALIVIZUMAB PACLITAXEL vs PALONOSETRON

Related Pages

PACLITAXEL Full Profile All Electrocardiogram qt prolonged Reports All Drugs Causing Electrocardiogram qt prolonged PACLITAXEL Demographics